术前18F-FDG PET/CT代谢指标与骨髓摄取模式对儿童神经母细胞瘤的预后价值
回顾性分析47例新诊断儿童神经母细胞瘤患者的治疗前18F-FDG PET/CT,评估代谢参数及骨髓摄取模式的预后价值。随访中27例(57.4%)复发;多因素分析显示TLG是RFS(P=0.016)和OS(P=0.012)的唯一独立预后因素,骨髓摄取模式和MTV对OS有统计学意义(分别为P=0.024和P=0.038)。结论认为治疗前18F-FDG PET/CT可提供可靠预后信息,高MTV、高TLG及局灶性骨髓摄取(单灶和多灶)患者后续治疗结局可能更差。
要点
- TLG是儿童神经母细胞瘤RFS(P=0.016)和OS(P=0.012)的唯一独立预后因素。
- 骨髓摄取模式和MTV对OS有统计学意义(P=0.024和P=0.038)。
- 高MTV、高TLG及局灶性骨髓摄取(单灶和多灶)患者结局可能更差。
核心结论
- 治疗前18F-FDG PET/CT可为儿童神经母细胞瘤患者提供可靠的预后信息。
- 高MTV、高TLG及局灶性骨髓摄取(单灶和多灶)患者后续治疗结局可能更差。
研究设计与样本
- 回顾性分析47例新诊断神经母细胞瘤患儿,均行治疗前18F-FDG PET/CT。
- 比较临床病理因素及代谢参数(SUVmax、MTV、TLG)和骨髓摄取模式,采用单因素和多因素分析预测无复发生存(RFS)和总生存(OS)。
主要发现
- 随访期间27例(57.4%)患者出现复发。
- MTV(P=0.001)、TLG(P=0.004)和骨髓摄取模式(P=0.025)为肿瘤复发的显著预测因素,同时肿瘤大小、组织学、分期、乳酸脱氢酶(LDH)及其他远处转移(除骨转移外)亦相关。
- 单因素分析显示组织学、分期、肿瘤大小(>37.25 cm)、其他远处转移、MTV(>88.10 cm³)、TLG(>1045.2 g)及骨髓摄取模式与RFS和OS均相关(P<0.05)。
- 多因素分析显示TLG是RFS(P=0.016)和OS(P=0.012)的唯一独立预后因素,骨髓摄取模式和MTV对OS有统计学意义(分别为P=0.024和P=0.038)。
关键数值与推荐
- 单因素分析中与RFS和OS相关的因素包括:组织学、分期、肿瘤大小>37.25 cm、其他远处转移、MTV>88.10 cm³、TLG>1045.2 g及骨髓摄取模式(P<0.05)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To evaluate the prognostic value of metabolic parameters and bone marrow uptake (BMU) patterns on pretherapeutic 18-F-fluorodeoxyglucose (18F-FDG) positron emission tomography/computed tomography (PET/CT) in pediatric patients with neuroblastoma (NB). PATIENTS AND METHODS: Forty-seven pediatric patients with newly diagnosed neuroblastoma who underwent 18F-FDG PET/CT were retrospectively reviewed. Clinicopathological factors and metabolic parameters including maximum standardized uptake value (SUVmax), metabolic tumor volume (MTV), total lesion glycolysis (TLG) and bone marrow uptake patterns on PET/CT were compared to predict recurrence-free survival (RFS) and overall survival (OS) by univariate and multivariate analysis. RESULTS: During the follow-up period, 27 (57.4%) patients experienced recurrence. MTV (P = 0.001), TLG (P = 0.004) and BMU patterns (P = 0.025) remained significant predictive factors for tumor recurrence, along with tumor size, histology, stage, lactate dehydrogenase (LDH) and other distant metastasis (except bone metastasis). Univariate analysis showed that histology, stage, tumor size (>37.25 cm), other distant metastasis, MTV (>88.10cm3) and TLG (>1045.2 g) and BMU patterns correlated with both RFS and OS (P < 0.05). On multivariate analysis, TLG remained the only independent prognostic factor for RFS (P = 0.016) and OS (P = 0.012), and BMU patterns and MTV were statistically significant for OS (P = 0.024 and P = 0.038, respectively). CONCLUSION: Pretherapeutic 18F-FDG PET/CT can provide reliable prognostic information for neuroblastoma pediatric patients, and patients with high MTV, TLG and focal bone marrow (unifocal and multifocal) uptake on PET/CT may have inferior outcomes during subsequent treatment.
引用
- Li C, Zhang J, Chen S, et al. Prognostic value of metabolic indices and bone marrow uptake pattern on preoperative 18F-FDG PET/CT in pediatric patients with neuroblastoma. Eur J Nucl Med Mol Imaging. 2017. PMID: 29110068. doi:10.1007/s00259-017-3851-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。